Paul Mahon
Förmögenhet: 24 M $ per 2026-06-30
Förmögenhet: 24 M $ per 2026-06-30
Paul A. Mahon is Co-Managing Director at Unither Therapeutik GmbH.
Mr. Mahon is Secretary, Executive VP & General Counsel at United Therapeutics Corp.
since 2003.
Mr. Mahon is Secretary, Executive VP & General Counsel at Miromatrix Medical, Inc. since 2023.
Mr. Mahon is partner at Hyperion Equity Partners Ltd. Mr. Mahon was Director at SteadyMed Ltd.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-07-16 | 45 172 ( 0,11 % ) | 24 M $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| UNITED THERAPEUTICS CORPORATION | Generell Rådgivare | 1996-06-26 |
| MIROMATRIX MEDICAL INC. | Generell Rådgivare | 2023-12-11 |
Unither Therapeutik GmbH
Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Verkställande Direktör | - |
| Företag | Position | Slut |
|---|---|---|
| STEADYMED LTD | Direktör/Styrelseledamot | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
United Therapeutics Corp.
United Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products to address the unmet medical needs of patients with chronic & life-threatening conditions | Health Technology |
Miromatrix Medical, Inc.
Miromatrix Medical, Inc. BiotechnologyHealth Technology Engages in research and development of fully biologic organs | Health Technology |
Unither Therapeutik GmbH
Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
SteadyMed Ltd.
SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, and manufacture of pharmaceutical products | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån